In its Q2 2026 investor letter, Hotchkis & Wiley Mid-Cap Value Fund highlighted Humana Inc. (NYSE:HUM).
Humana Inc. (NYSE:HUM), an American insurance company that provides medical and specialty insurance products, delivered strong performance during the quarter
On August 03, 2026, Humana Inc. (NYSE:HUM) closed at $374.50 per share. The one-month return of Humana Inc. (NYSE:HUM) was -5.10%, and its shares gained 47.17% over the past 52 weeks. Humana Inc. (NYSE:HUM) has a market capitalization of $44.97 billion.
Hotchkis & Wiley Mid-Cap Value Fund stated the following regarding Humana Inc. (NYSE:HUM) in its Q2 2026 investor letter: “Humana Inc. (NYSE:HUM) is one of the largest pure Medicare Advantage (MA) health insurer in the United States. Performance over the quarter was strong following news that the US agreed to increase 2027 payments for private MA plans above its initial proposal earlier in the year. The company’s stock has been undervalued due to higher utilization by enrollees and uncertainty regarding reimbursement rates.